Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
May 2010
Archives
Subscription
Features
Bisphosphonate Nephrotoxicity Risks and Use in CKD Patients
Difficult-to-Dose Opioids and the Risk Evaluation Mitigation Strategy
Memantine for the Treatment of Migraine
Neuropathic Pain: A Review of Diabetic Neuropathy
The Management of Acute Postoperative Pain
The Role of Parenteral NSAIDs in Postoperative Pain Control
Type 3 Diabetes: Brain Diabetes?
Departments
Consult Your Pharmacist
Self-Care Interventions for Back Pain
Contemporary Compounding
Clopidogrel 5 mg/mL Oral Suspension
Editorial
The Times They Are a-Changin'
Pharmacy Law
Health Care Reform Legislation: Part I
Senior Care
Chronic Opioid Therapy for Noncancer Pain
TrendWatch
Trends in Chronic Pain
What's News
Clinical Evidence That Anticancer Drug Triggers Viral Infection
What's News
Community Pharmacies Launch Initiative for Safe Medication Disposal
What's News
Patients Report More Depression-Medication Side Effects Than Charted
What's News
Statins May Slow Multiple Sclerosis Progression
Web Exclusive
Bisphosphonate Nephrotoxicity Risks and Use in CKD Patients
X
April 2024
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
• April 2026
• 2.00 Credits
Managing HIV Coinfections and Complications
Pain Management
• March 2026
• 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
Cardiovascular
• February 2026
• 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
×
Full Image